What seizure types is stiripentol used for (and what it’s not)?
Stiripentol is prescribed as an add-on treatment for people with Dravet syndrome, a childhood epilepsy syndrome. In practice, it is used specifically for seizure patterns that occur in Dravet syndrome—most notably convulsive (tonic-clonic) seizures and other seizure types seen in that condition.
Fenfluramine is also used in Dravet syndrome, but it has a different approved seizure-type focus. Where the two overlap, they are still not the same in what they are most directly targeted to treat. Fenfluramine’s labeled indication centers on reducing seizures that include generalized tonic-clonic seizures.
The key difference the label-focused question is pointing to is that stiripentol is indicated to treat convulsive seizure types in Dravet syndrome, including convulsive episodes beyond just generalized tonic-clonic seizures.
Which seizure types are typically listed for fenfluramine?
Fenfluramine’s approved use in Dravet syndrome is tied to reducing seizures described in prescribing information as generalized tonic-clonic seizures and associated seizure types within that syndrome.
So what seizure types does the stiripentol indication cover that fenfluramine doesn’t?
Compared with fenfluramine’s generalized tonic-clonic–centered indication, stiripentol’s approved use in Dravet syndrome includes a broader set of convulsive seizure presentations seen in the syndrome, not only generalized tonic-clonic seizures. In other words, stiripentol is used for Dravet-related convulsive seizures where generalized tonic-clonic seizures are a subset, not the sole defining seizure type.
What you can do next if you need the exact label wording
If you want the precise “stiripentol vs fenfluramine” seizure-type phrasing word-for-word (as it appears in the US label or EU/UK label), tell me your country/region (US, UK, EU, etc.) and whether you mean FDA/EMA labeling. Label wording varies by jurisdiction, and that affects the seizure-type list.